Network meta-analysis of randomized clinical trials: Reporting the proper summaries

Clinical Trials

Volumn 11, Issue 2, 2014, Pages 246-262

  Zhang, Jing ^a   Carlin, Bradley P ^a   Neaton, James D ^a   Soon, Guoxing G ^b   Nie, Lei ^b   Kane, Robert ^a   Virnig, Beth A ^a   Chu, Haitao ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTRIBUTABLE RISK; BAYES THEOREM; INTERMETHOD COMPARISON; META ANALYSIS (TOPIC); NETWORK META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; RISK RATIO; TREATMENT OUTCOME; HUMAN;

BAYES THEOREM; HUMANS; META-ANALYSIS AS TOPIC; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84898995197     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774513498322     Document Type: Article

References (63)

1. Egger M, Smith GD, Altman D Systematic Reviews in Health Care: Meta-Analysis in Context. 2 nd edn). BMJ Publishing Group, London, 2001. London: BMJ Publishing Group ; 2001:
2. Guyatt GH, Sackett DL, Sinclair JC, et al. Users' guides to the medical literature. JAMA. 1995 ; 274 (22). 1800-04
3. Li T, Puhan MA, Vedula SS, Singh S, Dickersin K. Network meta-analysis-highly attractive but more methodological research is needed. BMC Med. 2011 ; 9: 79
4. Higgins JPT, Whitehead A. Borrowing strength from external trials in a meta-analysis. Stat Med. 1996 ; 15 (24). 2733-49 (Pubitemid 27011054)
5. Caldwell DM, Ades A, Higgins J. Simultaneous comparison of multiple treatments: Combining direct and indirect evidence. BMJ. 2005 ; 331: 897-900 (Pubitemid 41502718)
6. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-treatments meta-analysis. Lancet. 2009 ; 373: 746-58
7. Cipriani A, Barbui C, Salanti G, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: A multiple-treatments meta-analysis. Lancet. 2011 ; 378: 1306-15
8. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: A network meta-analysis. Lancet. 2007 ; 369 (9557). 201-07 (Pubitemid 46111014)
9. Pahor M, Psaty BM, Alderman MH, et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: A meta-analysis of randomised controlled trials. Lancet. 2000 ; 356 (9246). 1949-54
10. Song F, Loke YK, Walsh T, et al. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: Survey of published systematic reviews. BMJ. 2009 ; 338: b1147
11. Palmerini T, Biondi-Zoccai G, Riva DD, et al. Stent thrombosis with drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis. Lancet. 2012 ; 379: 1393-402
12. Daniels J, Middleton L, Champaneria R, et al. Second generation endometrial ablation techniques for heavy menstrual bleeding: Network meta-analysis. BMJ. 2012 ; 344: e2564
13. Wang SY, Chu H, Shamliyan T, et al. Network meta-analysis of margin threshold for women with ductal carcinoma in situ. J Natl Cancer Inst. 2012 ; 104 (7). 507-16
14. Altman DG, Deeks JJ, Sackett DL. Odds ratios should be avoided when events are common. BMJ. 1998 ; 317: 1318 (Pubitemid 28502424)
15. Deeks J. When can odds ratios mislead? Odds ratios should be used only in case-control studies and logistic regression analyses. BMJ. 1998 ; 317: 1155-57
16. Sackett DL, Deeks JJ, Altman DG. Down with odds ratios!. Evid Based Med. 1996 ; 1: 164-66 (Pubitemid 126736726)
17. Davies HTO, Crombie IK, Tavakoli M. When can odds ratios mislead?. BMJ. 1998 ; 316: 989-91 (Pubitemid 28135151)
18. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR Introduction to Meta-Analysis. West Sussex: Wiley ; 2011:
19. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents. JAMA. 2003 ; 289 (19). 2534-44 (Pubitemid 37430155)
20. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, Nallamothu BK, Kent DM. Percutaneous coronary interventions for non-acute coronary artery disease: A quantitative 20-year synopsis and a network meta-analysis. Lancet. 2009 ; 373 (9667). 911-18
21. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med. 2002 ; 21 (16). 2313-24
22. Salanti G, Ades AE, Ioannidis JPA. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: An overview and tutorial. J Clin Epidemiol. 2011 ; 64 (2). 163-71
23. Chung H, Lumley T. Graphical exploration of network meta-analysis data: The use of multidimensional scaling. Clin Trials. 2008 ; 5 (4). 301-07
24. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004 ; 23: 3105-24 (Pubitemid 39334902)
25. Lu G, Ades AE. Assessing evidence inconsistency in mixed treatment comparisons. J Am Stat Assoc. 2006 ; 101: 447-59 (Pubitemid 43972289)
26. Lu G, Ades AE, Sutton AJ, et al. Meta-analysis of mixed treatment comparisons at multiple follow-up times. Stat Med. 2007 ; 26: 3681-99 (Pubitemid 47307743)
27. Lu G, Ades AE. Modeling between-trial variance structure in mixed treatment comparisons. Biostatistics. 2009 ; 10: 792-805
28. Jones B, Roger J, Lane PW, et al. Statistical approaches for conducting network meta-analysis in drug development. Pharm Stat. 2011 ; 10 (6). 523-31
29. White IR. Multivariate random-effects meta-regression: Updates to mvmeta. Stata J. 2011 ; 11 (2). 255-70
30. Manzoli L, Vito CD, Salanti G, et al. Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines. PloS One. 2011 ; 6 (9). e24384
31. Dias S, Welton NJ, Sutton AJ, Ades AE. Nice DSU technical support document 2: A generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials. National Institute for Health and Clinical Excellence ; London, UK ;..
32. Dias S, Welton NJ, Sutton AJ, Ades AE. Nice DSU technical support document 5: Evidence synthesis in the baseline natural history model. National Institute for Health and Clinical Excellence ; London, UK ;..
33. Dias S, Welton NJ, Sutton AJ, Ades AE. Nice DSU technical support document 6: Embedding evidence synthesis in probabilistic cost-effectiveness analysis: Software choices. National Institute for Health and Clinical Excellence ; London, UK ;..
34. Ibrahim JG, Chu H, Chen MH. Missing data in clinical studies: Issues and methods. J Clin Oncol. 2012 ; 30 (26). 3297-303
35. Little RJA, Rubin DB Statistical Analysis With Missing Data. 2 nd edn). John Wiley & Sons, New Jersey, 2002. New Jersey: John Wiley & Sons ; 2002:
36. Rubin DB. Inference and missing data. Biometrika. 1976 ; 63 (3). 581-92
37. Rubin DB Multiple Imputation for Nonresponse in Surveys. New York: Wiley Online Library ; 1987:
38. Schafer JL Analysis of Incomplete Multivariate Data. New York: Chapman & Hall/CRC ; 1997:
39. Salanti G, Higgins JPT, Ades AE, Ioannidis JPA. Evaluation of networks of randomized trials. Stat Methods Med Res. 2008 ; 17 (3). 279-301
40. White IR, Barrett JK, Jackson D, Higgins JPT. Consistency and inconsistency in network meta-analysis: Model estimation using multivariate meta-regression. Res Synth Methods. 2012 ; 3 (2). 111-25
41. Chu H, Nie L, Chen Y, Huang Y, Sun W. Bivariate random effects models for meta-analysis of comparative studies with binary outcomes: Methods for the absolute risk difference and relative risk. Stat Methods Med Res. 2012 ; 21 (6). 621-33
42. Gelman A. Prior distributions for variance parameters in hierarchical models. Bayesian Anal. 2006 ; 1 (3). 515-33
43. Gustafson P. The utility of prior information and stratification for parameter estimation with two screening tests but no gold standard. Stat Med. 2005 ; 24 (8). 1203-17 (Pubitemid 40485758)
44. Gustafson P, Hossain S, Macnab YC. Conservative prior distributions for variance parameters in hierarchical models. Can J Stat. 2006 ; 34 (4). 377-90 (Pubitemid 44784239)
45. Natarajan R, McCulloch CE. Gibbs sampling with diffuse proper priors: A valid approach to data-driven inference?. J Comput Graph Stat. 1998 ; 7 (3). 267-77
46. Lunn DJ, Thomas A, Best N, Spiegelhalter D. A Bayesian modeling framework: Concepts, structure, and extensibility. Stat Comput. 2000 ; 10 (4). 325-37
47. Lunn D, Spiegelhalter D, Thomas A, Best N. The BUGS project: Evolution, critique and future directions. Stat Med. 2009 ; 28 (25). 3049-67
48. Gelfand AE, Smith AFM. Sampling-based approaches to calculating marginal densities. J Am Stat Assoc. 1990 ; 85 (410). 398-409
49. Gilks WR, Best N, Tan K. Adaptive rejection metropolis sampling within Gibbs sampling. Appl Stat. 1995 ; 44 (4). 455-72
50. Brooks SP, Gelman A. General methods for monitoring convergence of iterative simulations. J Comput Graph Stat. 1998 ; 7 (4). 434-55 (Pubitemid 128635035)
51. Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences. Stat Sci. 1992 ; 7 (4). 457-72
52. Goodman SN. Toward evidence-based medical statistics. 1: The P value fallacy. Ann Intern Med. 1999 ; 130 (12). 995-1004 (Pubitemid 29283991)
53. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis. 1985 ; 27 (5). 335-71 (Pubitemid 15107153)
54. Hong H, Chu H, Zhang J, Carlin BP A Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons. Minneapolis, MN: Division of Biostatistics, University of Minnesota ; 2012:
55. Zhang J, Yu KF. What's the relative risk?. JAMA. 1998 ; 280 (19). 1690-91
56. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: A generalized estimating equation approach. Biometrics. 1988 ; 44 (4). 1049-60 (Pubitemid 19026037)
57. Caldwell DM, Welton NJ, Dias S, Ades AE. Selecting the best scale for measuring treatment effect in a network meta-analysis: A case study in childhood nocturnal enuresis. Res Synth Methods. 2012 ; 3 (2). 126-41
58. Achana FA, Cooper NJ, Dias S, et al. Extending methods for investigating the relationship between treatment effect and baseline risk from pairwise meta-analysis to network meta-analysis. Stat Med. 2012 ; 32 (5). 752-71
59. Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010 ; 29: 932-44
60. Higgins JPT, Jackson D, Barrett JK, et al. Consistency and inconsistency in network meta-analysis: Concepts and models for multi-arm studies. Res Synth Methods. 2012 ; 3: 98-110
61. van Valkenhoef G, Tervonen T, de Brock B, Hillege H. Algorithmic parameterization of mixed treatment comparisons. Stat Comput. 2012 ; 22: 1099-111
62. Jansen JP. Network meta-analysis of individual and aggregate level data. Res Synth Methods. 2012 ; 3: 177-90
63. Saramago P, Sutton AJ, Cooper NJ, Manca A. Mixed treatment comparisons using aggregate and individual participant level data. Stat Med. 2012 ; 31: 3516-36